Hermes Investment Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Hermes Investment Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-712,424	Closed	-$65.7M	–	234
2017 Q3	$65.7M	Buy	712,424 +61,307	+9%	+$5.89M	0.99%	28
2017 Q2	$73.6M	Buy	651,117 +19,893	+3%	+$2.22M	1.2%	20
2017 Q1	$63.2M	Buy	631,224 +301,828	+92%	+$32.3M	1.02%	30
2016 Q4	$35.4M	Buy	329,396 +8,028	+2%	+$939K	0.61%	67
2016 Q3	$40M	Buy	321,368 +54,641	+20%	+$6.45M	0.68%	58
2016 Q2	$28.4M	Buy	266,727 +53,214	+25%	+$6.18M	0.57%	77
2016 Q1	$24.6M	Buy	+213,513	New	+$25M	0.51%	80

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Hermes Investment Management's CBPO Position: Q4 2017 in Review

Hermes Investment Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2017, closing a stake of 712,424 shares — an estimated $65.7M sold.

Hermes Investment Management first reported a position in CBPO in Q1 2016 and held it in 7 quarters. The position peaked at $73.6M in Q2 2017. 93 funds tracked by Wall St. Rank hold CBPO as of Q4 2017.

Hermes Investment Management reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2017 after selling out during the quarter.
Hermes Investment Management sold 712,424 China Biologic Products Holdings, Inc. shares in Q4 2017, an estimated $65.7M.
Hermes Investment Management first reported a position in China Biologic Products Holdings, Inc. in Q1 2016 and held it in 7 quarters.
Hermes Investment Management's China Biologic Products Holdings, Inc. position peaked at $73.6M in Q2 2017.
93 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2017.

Based on Hermes Investment Management's 13F filing for Q4 2017, filed 24 Jan 2018.